dabigatran etexilate
Generic: dabigatran etexilate
Labeler: mylan pharmaceuticals inc.Drug Facts
Product Profile
Brand Name
dabigatran etexilate
Generic Name
dabigatran etexilate
Labeler
mylan pharmaceuticals inc.
Dosage Form
CAPSULE
Routes
Active Ingredients
dabigatran etexilate mesylate 150 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
0378-0266
Product ID
0378-0266_6c6b985e-111f-4fe9-a1ca-785c450e444b
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA208067
Listing Expiration
2026-12-31
Marketing Start
2025-02-25
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
03780266
Hyphenated Format
0378-0266
Supplemental Identifiers
RxCUI
UPC
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
dabigatran etexilate (source: ndc)
Generic Name
dabigatran etexilate (source: ndc)
Application Number
ANDA208067 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 150 mg/1
Packaging
- 60 CAPSULE in 1 BOTTLE, PLASTIC (0378-0266-91)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "6c6b985e-111f-4fe9-a1ca-785c450e444b", "openfda": {"upc": ["0303780266933"], "unii": ["SC7NUW5IIT"], "rxcui": ["1037045", "1037179"], "spl_set_id": ["baafb5be-ffe6-4755-a7ab-817b3c9b222d"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 CAPSULE in 1 BOTTLE, PLASTIC (0378-0266-91)", "package_ndc": "0378-0266-91", "marketing_start_date": "20250225"}], "brand_name": "Dabigatran Etexilate", "product_id": "0378-0266_6c6b985e-111f-4fe9-a1ca-785c450e444b", "dosage_form": "CAPSULE", "pharm_class": ["Direct Thrombin Inhibitor [EPC]", "Thrombin Inhibitors [MoA]"], "product_ndc": "0378-0266", "generic_name": "Dabigatran Etexilate", "labeler_name": "Mylan Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Dabigatran Etexilate", "active_ingredients": [{"name": "DABIGATRAN ETEXILATE MESYLATE", "strength": "150 mg/1"}], "application_number": "ANDA208067", "marketing_category": "ANDA", "marketing_start_date": "20250225", "listing_expiration_date": "20261231"}